Profil
Jonae R.
Barnes currently works at Atea Pharmaceuticals, Inc., as SVP-Investor Relations & Corporate Communications from 2021.
Ms. Barnes also formerly worked at Sumitomo Pharma America, Inc., as SVP-Investor Relations & Corporate Communications from 2007 to 2009, Agenus, Inc., as VP-Investor Relations & Corporate Communications, Idenix Pharmaceuticals LLC, as Head-Investor Relations, and Poxel SA, as Senior VP-Investor Relations & Public Relations.
Ms. Barnes received her graduate degree from Boston University and undergraduate degree from Suffolk University.
Aktive Positionen von Jonae R. Barnes
| Unternehmen | Position | Beginn |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 19.01.2021 |
Ehemalige bekannte Positionen von Jonae R. Barnes
| Unternehmen | Position | Ende |
|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Investor Relations Kontakt | 01.12.2009 |
| POXEL | Investor Relations Kontakt | - |
| AGENUS INC. | Investor Relations Kontakt | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Kontakt | - |
Ausbildung von Jonae R. Barnes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















